Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Blood Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma (HCC)

NCT05781568 is registered in ClinicalTrials.gov with Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis as lead sponsor.

NCT NCT05781568
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05781568 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Blood Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma (HCC)
Lead sponsor
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
Phase
Observational
Overall status
Unknown status
Start date
February 24, 2023
Completion date
January 27, 2025
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis, liver, hbv, hcc, hcv, nafld